The extinction of chronic viral hepatitis?
作者信息
Kumar Sonal, Jacobson Ira M
机构信息
Weill Cornell Medical College New York-Presbyterian Hospital New York NY.
Icahn School of Medicine at Mount Sinai Mount Sinai Beth Israel Medical Center New York NY.
出版信息
Clin Liver Dis (Hoboken). 2015 Sep 29;6(3):75-77. doi: 10.1002/cld.502. eCollection 2015 Sep.
Abstract
摘要
相似文献
1
The extinction of chronic viral hepatitis?慢性病毒性肝炎会灭绝吗？
Clin Liver Dis (Hoboken). 2015 Sep 29;6(3):75-77. doi: 10.1002/cld.502. eCollection 2015 Sep.
2
[Course of chronic hepatitis related to B virus in children. Study of serum viral DNA].
Gastroenterol Clin Biol. 1985 Jun-Jul;9(6-7):516-21.
3
Perihepatic lymphadenopathy in children with chronic viral hepatitis.慢性病毒性肝炎患儿的肝周淋巴结病
J Ultrason. 2015 Jun;15(61):137-50. doi: 10.15557/JoU.2015.0012. Epub 2015 Jun 30.
4
5
Transition of care between paediatric and adult gastroenterology. Chronic viral hepatitis.儿科与成人胃肠病学之间的护理过渡。慢性病毒性肝炎。
Best Pract Res Clin Gastroenterol. 2003 Apr;17(2):259-75. doi: 10.1016/s1521-6918(03)00014-3.
6
[Therapy of viral hepatitis].[病毒性肝炎的治疗]
Ther Umsch. 1998 Feb;55(2):71-6, 78-9.
7
The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.慢性病毒性肝炎、酒精中毒或肝硬化患者患肝癌和胆管癌的风险。
Hepatology. 2001 Oct;34(4 Pt 1):714-8. doi: 10.1053/jhep.2001.28233.
8
[Monitoring the course of non-A, non-B viral hepatitis in patients with chronic renal insufficiency].
Vnitr Lek. 1990 May;36(5):473-8.
9
[Evaluation of morbidity and etiological structure of acute and chronic viral hepatitis in the Sakha Republic (Yakutiia)].
Vopr Virusol. 2004 Jan-Feb;49(1):20-3.
10
Expression of oxidative stress-related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis.慢性病毒性肝炎患者循环白细胞和尿液中氧化应激相关分子的表达
Liver Int. 2006 Mar;26(2):157-65. doi: 10.1111/j.1478-3231.2005.01213.x.
本文引用的文献
1
Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus.用于对抗丙型肝炎病毒的直接作用抗病毒药物及相关诊断产品生产的最低目标价格。
Hepatology. 2015 Apr;61(4):1174-82. doi: 10.1002/hep.27641. Epub 2015 Feb 9.
2
Hepatitis B: future curative strategies.乙型肝炎：未来的治疗策略。
Curr Opin Infect Dis. 2014 Dec;27(6):528-34. doi: 10.1097/QCO.0000000000000110.
3
Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow.慢性乙型肝炎病毒感染除干扰素α和核苷（酸）类似物之外的治疗选择：对未来的期望。
J Viral Hepat. 2014 Nov;21(11):753-61. doi: 10.1111/jvh.12307.
4
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.特异性和非肝毒性降解乙型肝炎病毒cccDNA。
Science. 2014 Mar 14;343(6176):1221-8. doi: 10.1126/science.1243462. Epub 2014 Feb 20.
5
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.了解丙型肝炎病毒的生命周期为高效疗法铺平了道路。
Nat Med. 2013 Jul;19(7):837-49. doi: 10.1038/nm.3248.
6
Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010.2004-2010 年美国强化肝炎监测点报告的 HCV 感染病例检测指征。
Am J Public Health. 2013 Aug;103(8):1445-9. doi: 10.2105/AJPH.2013.301211. Epub 2013 Jun 13.
7
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.富马酸替诺福韦二吡呋酯治疗慢性乙型肝炎时肝硬化的逆转：一项 5 年开放标签随访研究。
Lancet. 2013 Feb 9;381(9865):468-75. doi: 10.1016/S0140-6736(12)61425-1. Epub 2012 Dec 10.
8
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy.抗病毒治疗预防乙型肝炎病毒相关肝细胞癌。
Hepatology. 2013 Jan;57(1):399-408. doi: 10.1002/hep.25937.
9
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.全球乙型肝炎病毒感染流行病学：特定年龄 HBsAg 血清流行率和地方性的新估计。
Vaccine. 2012 Mar 9;30(12):2212-9. doi: 10.1016/j.vaccine.2011.12.116. Epub 2012 Jan 24.
10
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.聚乙二醇干扰素和利巴韦林治疗对肝细胞癌的影响：晚期纤维化丙型肝炎患者的发生率和生存率。
J Hepatol. 2010 May;52(5):652-7. doi: 10.1016/j.jhep.2009.12.028. Epub 2010 Mar 4.
Zotero 插件